C2N Diagnostics launches new assay for Alzheimer’s disease
May 19, 2022 -- C2N Diagnostics debuted a high resolution mass spectrometry-based plasma tau multianalyte assay for research use only that can advance understanding of Alzheimer’s disease. Read More
Forge Biologics assembles scientific and manufacturing advisory board
May 18, 2022 -- Forge Biologics has created its new Scientific and Manufacturing Advisory Board filled with leaders in the field of gene therapy development and manufacturing. This independent panel represents Forge’s commitment to enhancing its gene therapy offerings through insights from experts in the field. Read More
Vida rolls out analysis services for clinical trials
May 17, 2022 -- Lung imaging software developer Vida Diagnostics has introduced a suite of retrospective data analysis services for sponsors of clinical trials at this week's American Thoracic Society conference in San Francisco. Read More
Precision BioSciences presents preclinical data for gene editing therapies
May 17, 2022 -- Precision BioSciences is scheduled to display preclinical data for its Arcus-based gene editing studies at the American Society of Gene & Cell Therapy’s annual meeting in Washington, DC. The showcase will include two oral presentations and two posters highlighting gene editing study results. Read More
PerkinElmer introduces ultrarapid whole-genome sequencing technology
May 17, 2022 -- PerkinElmer has launched a novel ultrarapid whole-genome sequencer to improve and accelerate diagnoses in intensive care settings. This ultrarapid whole-genome sequencing technology provided by PerkinElmer Genomics enables faster decision making for physicians, which is particularly important in critically ill patients. Read More
Danaher enters gene therapy consortium
May 16, 2022 -- Danaher has joined the Bespoke Gene Therapy Consortium, which generates gene therapy resources aimed at rare disorders. Read More
Lunaphore and Indica Labs combine spatial biology and pathology imaging platforms
May 13, 2022 -- Lunaphore and Indica Labs have partnered on the development of a biological research tool involving software from both companies. This new solution will involve a combination of Lunaphore’s Comet spatial biology platform and Indica Labs’ Halo digital pathology image analysis software. Read More
Komodo Health launches new publications management software
May 12, 2022 -- Komodo Health debuted Komodo Publications Planning, a publications management system designed to maximize the impact and outcome of scientific publications and medical communications in an accurate, efficient, and compliant manner. Read More
Study of T-cell behavior predicts therapeutic differences in cancer outcomes
May 10, 2022 -- Researchers at Weill Cornell Medicine have published a study in Cancer Cell revealing a novel insight on the role of T cells in cancer therapies. The study focused on comparing the differences in behaviors of T cells in immunotherapy for metastatic melanoma to treatment outcomes. Read More
Lunaphore launches Comet antibody instrument in U.K.
May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies instrument at Propath U.K., the first contract research organization in Europe to offer the service. Read More
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter